Skip to main navigation
Skip to search
Skip to main content
Western Sydney University Home
Research Profiles Login
Link opens in a new tab
Search content at Western Sydney University
Home
Profiles
Research outputs
Projects
Datasets
HDR theses
Activities
Press/Media
Prizes
Subjects
Research units
CD80/86 inhibitors : abatacept
Kevin D. Pile
, Garry G. Graham
, Stephen M. Mahler
Western Sydney University
School of Medicine
Research output
:
Chapter in Book / Conference Paper
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'CD80/86 inhibitors : abatacept'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Veterinary Science and Veterinary Medicine
B Cell
100%
T Cell
100%
T Cell Receptor
100%
Monocyte
100%
Disease-Modifying Antirheumatic Drug
100%
Medicine and Dentistry
Abatacept
100%
Combination Therapy
33%
T Cell
33%
B Cell
33%
Disease Modifying Antirheumatic Drug
33%
T Lymphocyte Receptor
33%
Chimeric Protein
33%
Kidney Graft
33%
Antigen
33%
Antirheumatic Agent
33%
Biological Response Modifier
33%
Belatacept
33%
Monocyte
33%
Immunology and Microbiology
Belatacept
25%
Biological Response Modifier
25%